Literature DB >> 19474804

Chemokine receptors in T-cell-mediated diseases of the skin.

Anke S Lonsdorf1, Sam T Hwang, Alexander H Enk.   

Abstract

The chemokine/chemokine receptor network is an integral element of the complex system of homeostasis and immunosurveillance. Initially studied because of their role in coordinating tissue-specific migration and activation of leucocytes, chemokines have been implicated in the pathogenesis of various malignancies and diseases with strong inflammatory components. We discuss recent findings suggesting a critical involvement of chemokine receptor interactions in the immunopathogenesis of classical inflammatory skin disorders such as psoriasis and atopic dermatitis, as well as neoplastic diseases with a T-cell origin, such as mycosis fungoides. A deeper understanding of the underlying contribution of the chemokine network in the disease processes is key for the development of selective targeted immunotherapeutics that may meet the delicate balance between efficacy and safety.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19474804     DOI: 10.1038/jid.2009.122

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  15 in total

1.  Interleukin-16 as a marker of Sézary syndrome onset and stage.

Authors:  Jillian Richmond; Marina Tuzova; Ashley Parks; Natalie Adams; Elizabeth Martin; Marianne Tawa; Lynne Morrison; Keri Chaney; Thomas S Kupper; Clara Curiel-Lewandrowski; William Cruikshank
Journal:  J Clin Immunol       Date:  2010-09-28       Impact factor: 8.317

2.  CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis.

Authors:  Ashley E Winkler; Joshua J Brotman; Meredith E Pittman; Nancy P Judd; James S Lewis; Robert D Schreiber; Ravindra Uppaluri
Journal:  Cancer Res       Date:  2011-07-06       Impact factor: 12.701

3.  CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.

Authors:  Vadim A Villarroel; Naoko Okiyama; Gaku Tsuji; Jay T Linton; Stephen I Katz
Journal:  J Invest Dermatol       Date:  2014-01-03       Impact factor: 8.551

4.  Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.

Authors:  Patrizia Fuschiotti; Adriana T Larregina; Johnan Ho; Carol Feghali-Bostwick; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2013-01

5.  Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome.

Authors:  M El-Domyati; W H El-Din; A F Rezk; I Chervoneva; J B Lee; M Farber; J Uitto; O Igoucheva; Vitali Alexeev
Journal:  Arch Dermatol Res       Date:  2021-04-17       Impact factor: 3.017

6.  Study of Molecular Mechanisms Involved in the Pathogenesis of Immune-Mediated Inflammatory Diseases, using Psoriasis As a Model.

Authors:  E S Piruzian; V V Sobolev; R M Abdeev; A D Zolotarenko; A A Nikolaev; M K Sarkisova; M E Sautin; A A Ishkin; An L Piruzyan; S A Ilyina; I M Korsunskaya; O Y Rahimova; S A Bruskin
Journal:  Acta Naturae       Date:  2009-10       Impact factor: 1.845

7.  Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.

Authors:  Janet Y Li; Steven Horwitz; Alison Moskowitz; Patricia L Myskowski; Melissa Pulitzer; Christiane Querfeld
Journal:  Cancer Manag Res       Date:  2012-03-12       Impact factor: 3.989

Review 8.  Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges.

Authors:  Maria Vela; Mariana Aris; Mercedes Llorente; Jose A Garcia-Sanz; Leonor Kremer
Journal:  Front Immunol       Date:  2015-01-30       Impact factor: 7.561

Review 9.  T cell homing to epithelial barriers in allergic disease.

Authors:  Sabina A Islam; Andrew D Luster
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 87.241

10.  CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis.

Authors:  Tomonori Takekoshi; Xuesong Wu; Hiroshi Mitsui; Yayoi Tada; Mandy C Kao; Shinichi Sato; Michael B Dwinell; Sam T Hwang
Journal:  J Invest Dermatol       Date:  2013-03-25       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.